Details for New Drug Application (NDA): 019625
✉ Email this page to a colleague
The generic ingredient in ELOCON is mometasone furoate. There are thirty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
Summary for 019625
Tradename: | ELOCON |
Applicant: | Merck Sharp Dohme |
Ingredient: | mometasone furoate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 019625
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.1% | ||||
Approval Date: | May 6, 1987 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.1% | ||||
Approval Date: | Apr 19, 2013 | TE: | RLD: | Yes |
Expired US Patents for NDA 019625
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck Sharp Dohme | ELOCON | mometasone furoate | CREAM;TOPICAL | 019625-001 | May 6, 1987 | See Plans and Pricing | See Plans and Pricing |
Merck Sharp Dohme | ELOCON | mometasone furoate | CREAM;TOPICAL | 019625-001 | May 6, 1987 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription